[On the question of possible irreversible disorders due to psychopharmacotherapy].
D000328:Adult; D001341:Autonomic Nervous System / Q000187:drug effects; D001712:Biperiden / Q000009:adverse effects; D002090:Butyrophenones / Q000009:adverse effects; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000009:adverse effects; D005116:Extrapyramidal Tracts; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced*; D010640:Phenothiazines / Q000009:adverse effects; D010946:Plants, Medicinal; D011398:Promethazine / Q000009:adverse effects; D011618:Psychotic Disorders / Q000188:drug therapy*; D011926:Rauwolfia / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014282:Trihexyphenidyl / Q000009:adverse effects
D002090:Butyrophenones; D010640:Phenothiazines; D014149:Tranquilizing Agents; D001712:Biperiden; D014282:Trihexyphenidyl; D011398:Promethazine; D002746:Chlorpromazine
Zur Frage möglicherweise irreversibler Störungen bei Psychopharmakotherapie.